FDA NDC Directory · JSON-LD · Markdown

Oxaliplatin

NDC 68083-170 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerGland Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA207385
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsOXALIPLATIN (50 mg/10mL)
Marketing started20170529
Package count1

External sources

Source: openFDA. Public-domain (CC0).